Video

Q&A With Zobair Younossi From Inova Fairfax Hospital: Hepatitis C Treatment Provides Fiscal Benefits as Well as Health Improvements

Author(s):

As hepatitis C becomes a curable condition in many parts of the world research is also showing the financial benefits of allowing once sick patients to resume their normal lives after treatment.

As hepatitis C becomes a curable condition in many parts of the world research is also showing the financial benefits of allowing once sick patients to resume their normal lives after treatment.

Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, from Inova Fairfax Hospital discussed what the advancements in treatment have meant to helping improve quality of life for patients and what work remains to be done during Digestive Disease Week in Washington DC. Younossi said even as recently as 5 years ago he could not have predicted how far treatment would have come and looks forward to seeing the condition's status in 5 more years.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.